Clinical Research & Pharmacovigilance education and onsite training institute, New Delhi that offers a wide range of job oriented training and educational programs with strong placement support. Some special features of Socrates School of Health courses are two months industry internships, guest lectures by Industry personal, top faculty from industry & academia and 100% job placement.
The program designed to give opportunities in an outstanding and exciting environment, with a major focus in training. A course designed to introduce the "nuts and bolts" of clinical research and pharmacovigilance with strong ethics program.
The program designed to cover all aspects of Clinical research, Pharmacovigilance and drug safety management. It sensitizes the students and equips them with knowledge on clinical trials and Pharmacovigilance practices worldwide and on the Indian scenario in detail. This course gives young executives an opportunity to remain ahead of competitors in a very nascent yet competitive environment. The prime objective is to provide a high-end training thereby enhancing the employment prospects of the participants.
To educate and prepare students, professionals in the field of clinical research, through research on the science and art of teaching and learning, the application of clinical processes, the effective uses of technology, within the ambit of ethics and a zeal to educate professionals in clinical research to serve the humanity.
To be the leaders in clinical research education and application of high quality services exceeding the beliefs of all our stakeholders. Our Endeavour is to constantly deliver the promise of cogent and lucid professional for rendering paramount services in the field of research.
The global pharmaceutical market in clinical research is estimated at US$ 427 billion, and research & development cost is estimated at US$ 60-65 billion annually. Two thirds of this amount is spent on drug development, i.e. approximately US$ 40 billion. Clinical Trials involve almost 70% of time and money of new drug development. The cost of conducting clinical trials for a new drug is approximately US$ 200-250 million.
The Pharmaceutical industry in India is valued at Rs. 90,000 cr. and is growing at the rate of 12 – 14 % per annum. India is rapidly emerging as a hub of Global Clinical trials & a destination for Drug Discovery & Development.
The study analyzes, key markets and segments of the concerned industry to project the future scenario of the clinical research industry. According to our industry experts, several steps need to be taken by the Indian government to ensure an easy approval system for promoting foreign investments. The report also studies various factors which are fuelling the growth of country’s clinical research market.
Clinical Trials market in India has shown significant growth in the recent past. Clinical Trial industry in India touched US$400 million in 2010, up from US$230 million in 2008 and is expected to touch US$1.09 billion by 2014. The cost of conducting clinical trials in developing countries like India and China is far lower when compared to their developed counterparts. The simple reasons are: Due to the multitude of benefits it offers, India has huge patient base, low cost advantage; can complete clinical trials on time; is improving its infrastructure with a strong government support.
Indian clinical research organizations (CROs) are now doing more complex and challenging studies contributing value addition to the drug development programs of their clients. Multinationals like Pfizer, Eli Lilly, Astrazeneca, Glaxo SmithKline and Bayer now get allied services work done in India.
Pharmaceutical giants are attracted by huge cost advantage in India. A data entry operator here costs around US$10-20 an hour compared to $30-50 in the developed economies while bio-statistician and medical writing professional charges are around $30-70 per hour in India as against US$100-150 in western countries.
India currently is the fastest growing destination for clinical research and so the demand for professionals in this field is growing rapidly. Clinical research is going to be a major provider of jobs here after IT sector.
The report “Booming Clinical Trials Market in India” provides an extensive research and rational analysis along with reliable statistics of the Indian clinical trial market. It studies the emerging market trends, recent developments, and their impact on the market. Besides, the report also provides complete details of the cost involved in various phases of clinical trials in the country. In addition, an in-depth analysis of the patient pool availability in India along with infrastructure and expertise has also been elucidated in the report. The report also reveals about the contribution of the government regulations in the growth of clinical trial industry in the country. Further, the report has also identified the process of starting clinical trials in the country. Competitive landscape is also provided in the report to enable clients with substantial understanding of the future market structure and growth potential.